MORRIS TIMOTHY E
Insider CIK 1191286 · KBIO COO and CFO, Director · AQST Director · IOVA Chief Financial Officer · ACRX Chief Financial Officer · DBVT Director · VVUS VP, Finance and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, In | A Award deriv | 2026-06-10 | 2026-06-12 | 50,500 | — | $0 | 50,500 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2025-06-11 | 2025-06-12 | 42,000 | $3.41 | $143.2K | 42,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2024-06-20 | 2024-06-21 | 38,000 | — | $0 | 38,000 | SEC↗ |
| DBVT DBV Technologies S.A. | P Buy | 2023-08-25 | 2023-08-28 | 12,000 | $1.52 | $18.2K | 12,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-06-21 | 2023-06-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-08-16 | 2022-08-17 | 28,500 | — | $0 | 28,500 | SEC↗ |
| HGEN HUMANIGEN, INC | A Award deriv | 2022-07-27 | 2022-07-29 | 600,360 | — | $0 | 600,360 | SEC↗ |
| HGEN HUMANIGEN, INC | A Award deriv | 2022-01-12 | 2022-01-14 | 59,841 | — | $0 | 59,841 | SEC↗ |
| HGEN HUMANIGEN, INC | A Award deriv | 2021-12-31 | 2022-01-04 | 51,000 | — | $0 | 51,000 | SEC↗ |
| DBVT DBV Technologies S.A. | P Buy deriv | 2021-06-10 | 2021-06-11 | 6,837 | $7.12 | $48.7K | 6,837 | SEC↗ |
| HGEN HUMANIGEN, INC | A Award deriv | 2020-09-18 | 2020-09-22 | 151,316 | — | $0 | 151,316 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2019-03-04 | 2019-03-06 | 100,000 | — | $0 | 100,000 | SEC↗ |
| HGEN HUMANIGEN, INC | A Award deriv | 2018-03-09 | 2018-03-13 | 88,235 | — | $0 | 88,235 | SEC↗ |
| HGEN HUMANIGEN, INC | A Award deriv | 2018-03-09 | 2018-03-13 | 715,877 | — | $0 | 715,877 | SEC↗ |
| IOVA IOVANCE BIOTHERAPEUTICS, I | A Award deriv | 2017-08-14 | 2017-08-16 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2017-02-07 | 2017-02-09 | 112,500 | — | $0 | 112,500 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2016-09-13 | 2016-09-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2016-02-10 | 2016-02-18 | 110,500 | — | $0 | 110,500 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2015-04-29 | 2015-05-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2014-12-02 | 2014-12-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2014-05-07 | 2014-05-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2013-09-05 | 2013-09-09 | 10,654 | — | $0 | 116,007 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2013-09-05 | 2013-09-09 | 10,654 | $4.23 | $45.1K | 10,654 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2013-09-05 | 2013-09-09 | 10,654 | $11.95 | $127.3K | 0 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2013-01-25 | 2013-01-29 | 8,540 | — | $0 | 8,540 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2013-01-25 | 2013-01-29 | 101,460 | — | $0 | 101,460 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-07-18 | 2012-07-20 | 25,000 | — | $0 | 126,661 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-07-18 | 2012-07-20 | 25,000 | $30.36 | $759.0K | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-07-18 | 2012-07-20 | 25,000 | $4.23 | $105.8K | 25,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-27 | 2012-02-27 | 20,544 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-27 | 2012-02-27 | 4,456 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-27 | 2012-02-27 | 25,000 | — | $0 | 151,661 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-02-27 | 2012-02-27 | 25,000 | $24.90 | $622.5K | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-27 | 2012-02-27 | 25,000 | $4.23 | $105.8K | 25,000 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-02-27 | 2012-02-27 | 4,456 | $22.93 | $102.2K | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-27 | 2012-02-27 | 4,456 | $5.67 | $25.3K | 4,456 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-02-27 | 2012-02-27 | 20,544 | $22.93 | $471.1K | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-27 | 2012-02-27 | 20,544 | $5.67 | $116.5K | 20,544 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-24 | 2012-02-27 | 25,000 | — | $0 | 20,544 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-02-24 | 2012-02-27 | 25,000 | $21.55 | $538.8K | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-24 | 2012-02-27 | 25,000 | $5.67 | $141.8K | 25,000 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-23 | 2012-02-27 | 4,267 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-23 | 2012-02-27 | 43,817 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-23 | 2012-02-27 | 91 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-23 | 2012-02-27 | 56,183 | — | $0 | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-23 | 2012-02-27 | 125,000 | — | $0 | 4,456 | SEC↗ |
| VVUS VIVUS INC | M Exercise deriv | 2012-02-23 | 2012-02-27 | 25,000 | — | $0 | 45,544 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-02-23 | 2012-02-27 | 125,000 | $20.69 | $2.59M | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-23 | 2012-02-27 | 125,000 | $5.67 | $708.8K | 125,000 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-02-23 | 2012-02-27 | 25,000 | $20.90 | $522.5K | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-23 | 2012-02-27 | 25,000 | $5.67 | $141.8K | 25,000 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-02-23 | 2012-02-27 | 43,817 | $20.69 | $906.6K | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-23 | 2012-02-27 | 43,817 | $4.25 | $186.2K | 43,817 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-02-23 | 2012-02-27 | 56,183 | $20.69 | $1.16M | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-23 | 2012-02-27 | 56,183 | $4.25 | $238.8K | 56,183 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-02-23 | 2012-02-27 | 91 | $20.69 | $1.9K | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-23 | 2012-02-27 | 91 | $4.15 | $378 | 91 | SEC↗ |
| VVUS VIVUS INC | S Sale | 2012-02-23 | 2012-02-27 | 4,267 | $20.69 | $88.3K | 0 | SEC↗ |
| VVUS VIVUS INC | M Exercise | 2012-02-23 | 2012-02-27 | 4,267 | $4.15 | $17.7K | 4,267 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2012-01-27 | 2012-01-31 | 8,970 | — | $0 | 8,970 | SEC↗ |
| VVUS VIVUS INC | A Award deriv | 2012-01-27 | 2012-01-31 | 81,030 | — | $0 | 81,030 | SEC↗ |